Antibodies to cyclic citrullinized peptide in rheumatoid arthritis

Aim. To estimate a diagnostic value of antibodies to cyclic citmllinized peptide (CCP) in rheumatoid arthritis (RA). Material and methods. The study was made of 85 RA patients. Of them, 48 patients had early RA, i.e. of 8 month and less duration. The control group consisted of 35 patients with non-d...

Full description

Bibliographic Details
Main Authors: E N Aleksandrova, N A Chemeris, D E Karateev, A A Novikov, K A Brodetskaya, E L Nasonov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2004-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/29967
id doaj-e8c8be9a842c42c5830002358a2e7468
record_format Article
spelling doaj-e8c8be9a842c42c5830002358a2e74682020-11-25T03:50:48Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422004-12-017912646826995Antibodies to cyclic citrullinized peptide in rheumatoid arthritisE N AleksandrovaN A ChemerisD E KarateevA A NovikovK A BrodetskayaE L NasonovAim. To estimate a diagnostic value of antibodies to cyclic citmllinized peptide (CCP) in rheumatoid arthritis (RA). Material and methods. The study was made of 85 RA patients. Of them, 48 patients had early RA, i.e. of 8 month and less duration. The control group consisted of 35 patients with non-differentiated arthritis (NBA) and 8 healthy donors. Concentrations of CCP antibodies, rheumatoid factor (RF) IgM and RF IgA were measured with enzyme immunoassay (EIA). Results. The level of CCP antibodies in RA patients (76.3 ± 43.8; median 100.0 U/ml) was significantly higher than in NDA patients (25.1 ± 43.9; median 0.8 U/ml; p < 0.05) or in donors (0.38 ± 0.36; median 0.2 U/ml; p < 0.05). A correlation was found between the CCP antibodies level and that ofRF IgM (/ = 15.4; p = 0.001) and RF IgA (/ = 10.3; p = 0.001). Sensitivity (82%) and specificity (90%) of CCP antibodies in RA diagnosis was higher than these parameters for RF IgM and IgA (78%o, 86%> and 72%, 83%, respectively). Simultaneous tests for CCP antibodies, RF IgM and RF IgA led to a 93% specificity. CCP antibodies were detected in 50% patients seronegative by RF IgM and in 62% patients seronegative by IgA. Detection of CCP antibodies was closely associated with early RA (x2 = 30.8;p = 0.0001). Conclusion. The EI A for CCP antibodies is a sensitive and specific serological test for early RA diagnosis.https://ter-arkhiv.ru/0040-3660/article/view/29967antibodies to cyclic citrullinized peptiderheumatoid factorrheumatoid arthritis
collection DOAJ
language Russian
format Article
sources DOAJ
author E N Aleksandrova
N A Chemeris
D E Karateev
A A Novikov
K A Brodetskaya
E L Nasonov
spellingShingle E N Aleksandrova
N A Chemeris
D E Karateev
A A Novikov
K A Brodetskaya
E L Nasonov
Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
Терапевтический архив
antibodies to cyclic citrullinized peptide
rheumatoid factor
rheumatoid arthritis
author_facet E N Aleksandrova
N A Chemeris
D E Karateev
A A Novikov
K A Brodetskaya
E L Nasonov
author_sort E N Aleksandrova
title Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
title_short Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
title_full Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
title_fullStr Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
title_full_unstemmed Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
title_sort antibodies to cyclic citrullinized peptide in rheumatoid arthritis
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2004-12-01
description Aim. To estimate a diagnostic value of antibodies to cyclic citmllinized peptide (CCP) in rheumatoid arthritis (RA). Material and methods. The study was made of 85 RA patients. Of them, 48 patients had early RA, i.e. of 8 month and less duration. The control group consisted of 35 patients with non-differentiated arthritis (NBA) and 8 healthy donors. Concentrations of CCP antibodies, rheumatoid factor (RF) IgM and RF IgA were measured with enzyme immunoassay (EIA). Results. The level of CCP antibodies in RA patients (76.3 ± 43.8; median 100.0 U/ml) was significantly higher than in NDA patients (25.1 ± 43.9; median 0.8 U/ml; p < 0.05) or in donors (0.38 ± 0.36; median 0.2 U/ml; p < 0.05). A correlation was found between the CCP antibodies level and that ofRF IgM (/ = 15.4; p = 0.001) and RF IgA (/ = 10.3; p = 0.001). Sensitivity (82%) and specificity (90%) of CCP antibodies in RA diagnosis was higher than these parameters for RF IgM and IgA (78%o, 86%> and 72%, 83%, respectively). Simultaneous tests for CCP antibodies, RF IgM and RF IgA led to a 93% specificity. CCP antibodies were detected in 50% patients seronegative by RF IgM and in 62% patients seronegative by IgA. Detection of CCP antibodies was closely associated with early RA (x2 = 30.8;p = 0.0001). Conclusion. The EI A for CCP antibodies is a sensitive and specific serological test for early RA diagnosis.
topic antibodies to cyclic citrullinized peptide
rheumatoid factor
rheumatoid arthritis
url https://ter-arkhiv.ru/0040-3660/article/view/29967
work_keys_str_mv AT enaleksandrova antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
AT nachemeris antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
AT dekarateev antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
AT aanovikov antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
AT kabrodetskaya antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
AT elnasonov antibodiestocycliccitrullinizedpeptideinrheumatoidarthritis
_version_ 1724490474684678144